Sign Up
OverviewAPI
The regenerative medicine market is projected to reach $49.0 billion by 2028, with a CAGR of 25.1% from 2023 to 2028. Key players include Novartis AG, Biogen, Inc., Gilead Sciences, Inc., and others. North America leads, while the APAC region shows promising growth potential. The market is fueled by collaborations, personalized medicine focus, and regulatory approvals.

Ask a question